CG Oncology
CGON
CGON
175 hedge funds and large institutions have $3.13B invested in CG Oncology in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 161 → 175 (+14)
2.25% more ownership
Funds ownership: 99.59% → 101.84% (+2.2%)
5% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 57
Holders
175
Holding in Top 10
12
Calls
$7.79M
Puts
$1.18M
Top Buyers
| 1 | +$146M | |
| 2 | +$27M | |
| 3 | +$24.7M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$11M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.78M |
Top Sellers
| 1 | -$49.4M | |
| 2 | -$39.8M | |
| 3 | -$28.5M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$20M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$18.2M |
